Nalu Medical, Inc. Raises $50M for Neurostimulation System

Nalu Medical, Inc., a privately held medical device company, has successfully secured $50,000,000 in investment capital from investors. This funding announcement signifies a pivotal moment for the Carlsbad, California-based firm as it continues to advance its neurostimulation technologies. The company specializes in developing innovative solutions for chronic pain management. Its flagship product, the Nalu neurostimulation system, is a battery-free, micro-implantable pulse generator (iPG). This system has received clearance from the FDA for both Spinal Cord Stimulation (SCS) and Peripheral Nerve Stimulation (PNS), designed to mitigate chronic pain effectively. The Nalu system is recognized for its high capability and easy upgradeability, providing a diverse menu of therapy options to patients and healthcare providers. This significant capital infusion underscores investor confidence in Nalu Medical's technology and its potential within the growing chronic pain market. The $50 million investment will be strategically deployed to accelerate the company’s growth initiatives. Nalu Medical plans to utilize these funds to further advance its product development pipeline, scale its commercial operations, and expand market access for its neurostimulation system, with the ultimate goal of reaching a wider patient population. The securing of this investment is expected to bolster Nalu Medical's competitive standing in the neurostimulation sector. This financial milestone positions the company for sustained growth, enabling it to continue its mission of delivering advanced and less invasive treatment options to individuals living with chronic pain, thereby expanding its impact in the medical device industry.